Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03404375 · ClinicalTrials.gov registry record · NA
Validating a New Method to Assess Estimated Blood Loss in the Obstetric Population
A NA study, sponsored by The University of Texas Medical Branch, Galveston.
- Completed
- Registry status
- NA
- Development phase
- 242
- Enrollment target
NCT03404375 is a NA study that has completed, run by The University of Texas Medical Branch, Galveston. The registered enrollment target is 242 participants.
The verdict
NCT03404375, a NA study, has completed, sponsored by The University of Texas Medical Branch, Galveston.
- COMPLETED
- Registry status
- NA
- Development phase
- 242 participants
- Enrollment target
Study Summary
Postpartum hemorrhage (PPH) is the leading cause of maternal mortality in low-income countries and the primary cause of nearly one quarter of all maternal deaths globally. Estimates of blood loss at delivery are notoriously inaccurate, with under-estimation more common than over-estimation. Traditionally, the surgeon performing the cesarean section would estimate the blood loss by visually assessing the blood collected in the surgical drape and counting the number of lap sponges used thru out the procedure. The investigators would like to study and validate an FDA approved device called the gauss Triton device used to estimate blood loss during scheduled cesarean sections.
Interventions
- DEVICE Gauss Triton system
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 242 participants |
| Start Date | 2018-03-01 |
| Est. Completion | 2018-12-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03404375
The ClinicalTrials.gov registry entry for NCT03404375 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 242 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is The University of Texas Medical Branch, Galveston, which has 203 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Gauss Triton system is the first listed.
NCT03404375 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03404375 about?
NCT03404375 is a clinical study titled "Validating a New Method to Assess Estimated Blood Loss in the Obstetric Population". Postpartum hemorrhage (PPH) is the leading cause of maternal mortality in low-income countries and the primary cause of nearly one quarter of all maternal deaths globally. Estimates of blood loss at delivery are notoriously inaccurate, with under-estimation more common than over-estimation. Traditio...
What is the current status of trial NCT03404375?
This trial is currently completed. It is a NA study. The enrollment target is 242 participants. The study started on 2018-03-01. Estimated completion is 2018-12-01.
What interventions are being tested in trial NCT03404375?
The interventions under investigation include: Gauss Triton system (DEVICE).
Who is sponsoring clinical trial NCT03404375?
This trial is sponsored by The University of Texas Medical Branch, Galveston, which has 203 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.